Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,992 | 119 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $359.05 | 20 | $0 (2023) |
| Novo Nordisk Inc | $347.80 | 27 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $156.31 | 10 | $0 (2023) |
| Lilly USA, LLC | $131.59 | 8 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $122.36 | 6 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $99.12 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $98.82 | 6 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $97.43 | 4 | $0 (2022) |
| Dermavant Sciences, Inc. | $95.13 | 1 | $0 (2024) |
| Amgen Inc. | $85.13 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $162.72 | 5 | Dermavant Sciences, Inc. ($95.13) |
| 2023 | $451.00 | 25 | ABBVIE INC. ($176.47) |
| 2022 | $1,322 | 86 | Novo Nordisk Inc ($268.39) |
| 2021 | $55.55 | 3 | AbbVie Inc. ($25.93) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $95.13 | General |
| Category: DERMATOLOGY | ||||||
| 06/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Immunology | ||||||
| 03/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Immunology | ||||||
| 03/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Immunology | ||||||
| 10/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/15/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Diabetes | ||||||
| 04/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 03/13/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Hematology | ||||||
| 03/10/2023 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: WOMENS HEALTH | ||||||
| 03/03/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: ANTIBIOTIC | ||||||
| 02/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Oncology | ||||||
| 02/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 02/14/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Neuroscience | ||||||
| 02/09/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: PAIN | ||||||
| 02/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 02/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/26/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,663 | 2,668 | $268,364 | $76,208 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 272 | 278 | $45,870 | $14,740 | 32.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 207 | 215 | $40,420 | $11,771 | 29.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 173 | 173 | $34,946 | $11,463 | 32.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 143 | 146 | $40,150 | $9,670 | 24.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 307 | 323 | $38,760 | $9,296 | 24.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 131 | 158 | $16,274 | $5,638 | 34.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 233 | 1,088 | $21,760 | $4,378 | 20.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 39 | 39 | $11,583 | $4,192 | 36.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 66 | 84 | $7,980 | $2,591 | 32.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 31 | 31 | $5,797 | $1,386 | 23.9% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 18 | $3,204 | $832.05 | 26.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 20 | $860.00 | $171.76 | 20.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 95 | $760.00 | $78.21 | 10.3% |
About Lindsey Koach, DNP
Lindsey Koach, DNP is a Primary Care healthcare provider based in Franklin, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2021. The National Provider Identifier (NPI) number assigned to this provider is 1255007357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lindsey Koach, DNP has received a total of $1,992 in payments from pharmaceutical and medical device companies, with $162.72 received in 2024. These payments were reported across 119 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,992).
As a Medicare-enrolled provider, Koach has provided services to 1,663 Medicare beneficiaries, totaling 2,668 services with total Medicare billing of $76,208. Data is available for 1 year (2023–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Location Franklin, NC
- Active Since 08/18/2021
- Last Updated 08/18/2021
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1255007357
Products in Payments
- VRAYLAR (Drug) $232.21
- Rybelsus (Drug) $172.36
- STIOLTO RESPIMAT (Drug) $105.13
- XIFAXAN (Drug) $99.12
- LEQVIO (Drug) $98.82
- Kerendia (Drug) $97.43
- VTAMA (Drug) $95.13
- Ozempic (Drug) $82.36
- SOLIQUA 100/33 (Biological) $74.40
- EMGALITY (Drug) $66.49
- TRULICITY (Drug) $65.10
- Saxenda (Drug) $63.67
- XARELTO (Drug) $48.60
- LINZESS (Drug) $48.58
- NURTEC ODT (Drug) $41.57
- UBRELVY (Drug) $40.89
- Otezla (Drug) $40.70
- EVENITY (Biological) $32.38
- FARXIGA (Drug) $31.70
- Sotyktu (Drug) $30.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Franklin
Ashley Heinly, Aprn, Fnp-C, APRN, FNP-C
Primary Care — Payments: $2,325
Mr. Samuel Paris, Cpnp-Pc, CPNP-PC
Primary Care — Payments: $1,298
Tiffany Balin, Np-C, NP-C
Primary Care — Payments: $1,068
Mrs. Ellen Ehleben
Primary Care — Payments: $875.57
Kelsey Johnson, Fnp, FNP
Primary Care — Payments: $122.85
Ashlynn Matthews, Np, NP
Primary Care — Payments: $108.64